STAT3 and acute myeloid leukemia: STAT3 inhibitor does not block calcitriol-induced PD-L1 expression in THP1 AML cells: In AML and MDS, STAT3 serves as a pro-leukemogenic transcription factor that is associated with poor prognosis and short disease-free survival [27].